DRDébora Kurrle Rieger

Débora Kurrle Rieger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Débora Kurrle Rieger has a total of 195 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Modified Atkins diet therapy in adult drug‐resistant epilepsy: Quality of life and mental health outcomes

    by Raquel Alencastro Veiga Domingues Carneiro, Rosa Mendes Cardoso, Mariana dos Santos Lunardi, Maiara Cristina Lima, Sedigheh Anzani, Amanda Xavier Darella, Maria Teresa Salvador, Thalia de Paula Moraes, Nicole de Carvalho Sostizzo, Débora Kurrle Venske, et al.

    Objective: This study aims to assess the effect of ketogenic diet therapy on seizure frequency, quality of life, and mental health symptoms in adults with drug‐resistant epilepsy (DRE). Methods: We conducted a longitudinal, quantitative, prospective, and single‐center cohort study. Patients were recruited from a tertiary health care center in Brazil. The modified Atkins diet was prescribed to adult (≥18 years old) patients with DRE. Patients were accompanied closely by a specialized team of doctors and nutritionists, with a nutritionist available 24/7. Blood ketone levels were measured using a β‐hydroxybutyrate meter and corresponding test strips. Patients were instructed to record all events in a seizure diary and completed questionnaires (Quality of Life in Epilepsy Inventory 31 [QOLIE‐31], Hospital Anxiety and Depression Scale [HADS], and Adult Self‐Report Scale [ASRS]) during the follow‐up period to evaluate mental health and quality of life. Joint multiple imputation was used to address missing data, and statistical analysis was performed with linear mixed models. Results: A total of 17 patients were included, of whom nine were followed up for a total of 12 months and six for 6 months, and two completed 3 months of diet. Ten of the patients presented with focal to bilateral tonic–clonic seizures, and only one had generalized epilepsy. At 12 months of diet, QOLIE‐31 scores increased significantly (+17.21, p = .043, 95% confidence interval [CI] = .56–33.86), and anxiety scores (HADS‐A) also showed a significant improvement (−4.38, p = .01, 95% CI = −7.63 to −1.07). No significant changes were observed in seizure frequency or ASRS. Significance: In this single‐arm prospective cohort study, modified Atkins diet therapy was associated with improved quality of life and reduced anxiety symptoms in adults with DRE, independent of major changes in seizure frequency.


  • Open Access

    Nutrition practice and research in the age of nutritional neuroscience

    by Júlia Dubois Moreira, Gilciane Ceolin, Letícia Carina Ribeiro, Luciana da Conceição Antunes, Débora Kurrle Riege

    Objective To explore current issues regarding the inclusion of nutritionists in Nutritional Neuroscience, addressing key concepts, main areas of research, and their potential, in addition to knowledge gaps requiring further attention.

  • Open Access

    Atuação do nutricionista em neurociência nutricional

    by Júlia Dubois Moreira, Gilciane Ceolin, Letícia Carina Ribeiro, Luciana da Conceição Antunes, Débora Kurrle Riege

    Objetivo Discutir temas atuais da inserção do nutricionista na área da Neurociência Nutricional, abordando conceitos, as principais áreas de investigação e suas potencialidades, além das lacunas que necessitam de mais foco.

  • Open Access

    Culinary recipes adaptation to a cooking skills intervention program for individuals with type 2 diabetes: a feasibility study

    by Camila Vieira Tiecher, Ana Carolina Fernandes, Greyce Luci Bernardo, Fharlley Lohann de Medeiros Rodrigues da Silva, Ana Paula Gines Geraldo, Tailane Scapin, Vanessa Mello Rodrigues, Débora Kurrle Rieger, Paula Lazzarin Uggioni, Rossana Pacheco da Costa Proença

    Introduction: Healthy eating habits and cooking skills can contribute to the treatment of type 2 diabetes mellitus (T2DM). Objective: This study aimed to adapt, test, and qualitatively evaluate the sensory characteristics of food recipes for their application in a culinary intervention program for individuals with type 2 diabetes, called Nutrition and Culinary in the Kitchen. Methods: Nutrition and Culinary in the Kitchen is an intervention program with hands-on cooking classes focused on promoting cooking skills. Recipes’ modifications were based on the glycemic index of ingredients, then tested and discussed by nutrition experts in consensus workshops. Individuals with type 2 diabetes assessed and discussed the sensory characteristics of recipes in focus groups. Results: Recipes adaptations to suit type 2 diabetes population included replacement of rice by cauliflower and pasta by zucchini, and the use of fruits and spices in sweet recipes instead of using added sugar ingredients and/or non-caloric sweeteners. Those changes were positively accepted by the individuals with type 2 diabetes. Conclusion: The adapted culinary recipes can be used in dietary guidelines and in cooking interventions to promote eating habits that contribute to glycemic control.


  • Open Access

    SEVERIDADE DAS CRISES EPILÉPTICAS E QUALIDADE DE VIDA DOS PACIENTESCOM EPILEPSIA FARMACORRESISTENTE EM USO DE DIETA CETOGÊNICA

    by Saulo André Benincá, Júlia Dubois Moreira, Letícia Carina Ribeiro Da Silva, Débora Kurrle Rieger Venske, Maiara Cristina De Lima, Katia Lin, Mariana dos Santos Lunardi

    RESUMOObjetivos: Analisar em uma população de pacientes brasileiros com Epilepsia Farmacorresistente (EFR) realizando DC se a severidade das crises piora a QV dos mesmos. Métodos: Estudo analítico observacional transversal. Dados clínico-demográficos foram obtidos dos pacientes, que responderam aos questionários GASE e SSQ para aferir a severidade da epilepsia, bem como a um inventário para diagnóstico de depressão e ansiedade (HADS-D e HADS-A) e QOLIE-31 para estimar a qualidade de vida. Resultados: Foram entrevistados 10 pacientes, no período de janeiro a setembro de 2019. A média de idade de 34,7 anos, 50% do sexo feminino e média de escolaridade de 11 anos. Os pacientes obtiveram pontuação média de 3,70 na escala GASE, 9,20 na HADS-A, 7,90 na HADS-D e 50,92 na escala QOLIE-31. Houve correlação estatisticamente significante entre as escalas HADS-A e HADS-D (r: 0,886, p=0.001) e entre HADS-A e QOLIE-31 (r: -0,649, p=0.042). Conclusão: A severidade das crises epilépticas em pacientes com EFR em uso de DC não pode ser correlacionada com a QV.

  • Ketogenic diet, epilepsy and cognition: what do we know so far? A systematic review

    by Maiara Cristina Lima, Mariana Papini Gabiatti, Júlia Dubois Moreira, Leticia Carina Ribeiro, Mariana dos Santos Lunardi, Katia Lin, Débora Kurrle Venske

    Epilepsy is a chronic neurological disorder that has social, cognitive, and psychological consequences to the patient. The effects of the ketogenic diet (KD) in children and adults with pharmacoresistant epilepsy on cognitive function were evaluated in this systematic review. The MEDLINE, Cochrane Library, Scopus, Web of Science, and LILACS databases were searched up to February 2021. From the 2973 records initially identified, 24 studies were included in the systematic review. These records were screened via PICO criteria, focusing on studies that evaluated the effects of KD on cognitive function of patients with pharmacoresistant epilepsy. Nineteen studies described improvements in cognitive function attributed to KD; improvements were not observed in 2 studies, but neither was aggravation. Contradictory results were reported in 3 studies, depending on the method used to assess cognition. At first glance, cognitive function appears to be associated with the number of seizures, diet effectiveness, amount of carbohydrate ingested, and antiseizure medication used. However, due to the diversity of methods used to assess cognitive function, especially self-perception of cognitive improvement by the patient, it was not possible to confirm this hypothesis. It was not possible to confirm if KD itself promotes improvements in cognitive function in patients with pharmacoresistant epilepsy. Certainly, more studies are needed with better methodological quality, larger and more homogeneous samples in relation to epileptic syndrome and clinical aspects of the disease, more rigid monitoring of adherence to the diet, and use of standardized tests for neuropsychological assessment. Systematic Review Registration: PROSPERO registration no. CRD42019129236


  • Efficacy and tolerability of the ketogenic diet and its variations for preventing migraine in adolescents and adults: a systematic review

    by Madson C Caminha, Adriana B Moreira, Filipe C Matheus, Débora K Rieger, Júlia D Moreira, Eduardo M Dalmarco, Izabel G Demarchi, Katia Lin

    Context: Migraine is a headache of variable intensity that is associated with focal and systemic symptoms. A ketogenic diet (KD), a very-low-carbohydrate diet with a proportional increase in fat, causes brain metabolic alterations, which could be beneficial for some neurologic conditions. Objective: A systematic review was conducted to assess the efficacy and tolerability of KD in preventing migraine in adolescents and adults. Data sources: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses standard was used to review articles found in the PubMed, EMBASE, Scopus, Web of Science, LILACS, LIVIVO, Science Direct, and Cochrane Central Register of Controlled Trials databases. The Google Scholar, DOAJ, ProQuest, and OpenGrey databases were included. Data Extraction: The population, intervention, comparison, outcome, and study design strategy included assessing the quality of the evidence using Grading of Recommendations Assessment Development and Evaluation and the risk of bias after applying the JBI critical appraisal tools. Data Analysis: Most of the 10 selected studies reported that KD reduced the number and severity of migraine attacks in patients, with few reported adverse effects. The evidence on the effectiveness of the KD is low, so whether the final effect is due to the treatment remains inconclusive. Conclusions: This study represents an initial effort to systematize information on the efficacy and tolerability of KD and its variations in the prevention of migraine. Systematic Review Registration: PROSPERO registration no. CRD42020186253


  • Effects of Euterpe edulis Martius on inflammatory responses to high-intensity intermittent exercise: Crossover randomized trial

    by Bruna Cunha Mendes, Cândice Laís Knöner Copetti, Vilma Simões Pereira Panza, Lucas B.R. Orssatto, Julia Salvan da Rosa, Fernando Diefenthaeler, Eduardo Monguilhott Dalmarco, Patricia Faria Di Pietro, Débora Kurrle Rieger


  • Open Access

    Efeito de dietas hiperproteicas nas adaptações musculares induzidas pelo treinamento resistido: revisão de literatura

    by Débora Kurrle Rieger, João Pedro Faraco, Bruna Cunha Mendes

    O objetivo do estudo foi analisar o efeito de dietas hiperproteicas nas adaptações musculares em indivíduos praticantes de treinamento resistido, assim como relatar possíveis alterações em dosagens bioquímicas de hormônios anabólicos. Foi realizada uma revisão da literatura nas bases de dados online PubMed, Scopus e Web of Science. Os estudos encontrados analisaram o efeito da ingestão de proteínas em quantidades a partir de 0,8 g/kg/dia até 4,4 g/kg/dia em períodos de duas a dezesseis semanas. Corroborando com a International Society of Sports Nutrition, Academy of Nutrition and Dietetics, Dietitians of Canada, American College of Sports Medicine e Nutrition guidelines for strentgh sports: Sprinting, weightlifting, throwing events, and bodybuilding, a presente revisão aponta que a ingestão de proteínas visando a hipertrofia muscular em praticantes de treinamento resistido, deve ser de aproximadamente 2 g/kg/dia. Quantidades acima deste valor não resultam em maior aumento de massa muscular em praticantes de treinamento resistido.

  • Open Access

    Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil

    by Gilciane Ceolin, Luísa Harumi Matsuo, Susana Cararo Confortin, Eleonora D’oRsi, Débora Kurrle Rieger, Júlia Dubois Moreira

    Background: Older adults are one of the most susceptible populations to depression, especially those living in low- and middle-income countries. As well, they are also considering a risk group for vitamin D deficiency. Low serum vitamin D has been associated with an increased risk of brain neuropsychiatry disorders. We aimed to investigate the association between serum 25-hydroxycholecalciferol concentrations and depressive symptoms in adults aged 60 years and over from southern Brazil.Methods: A cross-sectional analysis was performed using data collected during 2013–2014 from the populational-based longitudinal EpiFloripa Aging Study (n = 1197). Serum 25-hydroxycholecalciferol concentrations were analyzed and classified according to the Endocrine Society reference values [sufficiency (≥ 30 ng/mL), insufficiency (21–29 ng/mL), and deficiency (≤ 20 ng/mL)]. Depressive symptoms were evaluated using the Geriatric Depression Scale (15-item GDS). Logistic regression was performed to assess depressive symptoms in each vitamin D category. The analysis was adjusted for sex, age, skin color, family income, leisure-time physical activities, social or religious groups attendance, morbidities, cognitive impairment, and dependence in activities of daily living.Results: A total of 557 participants with complete data for exposure and outcome were enrolled in the analysis. Most of the sample participants were female (63.1%), age-range 60–69 years (42.2%), white skin color (85.1%), and vitamin D serum level samples were collected in autumn (50.7%). Depressive symptoms were present in 15.8% of the participants, and the prevalence was higher in individuals classified as deficient in vitamin D (23.2, 95% confidence interval [CI] = 15.6;32.9) and insufficiency (17.2, 95%CI = 11.0;25.9). The crude analysis showed that vitamin D deficient participants had 3.08 (CI = 1.53;6.20) times higher odds to present depressive symptoms compared to vitamin D sufficiency. After adjusting, the association was maintained [OR 2.27 (95%CI = 1.05;4.94).Conclusions: Serum 25-hydroxycholecalciferol deficiency was positively associated with depressive symptoms in older adults from southern Brazil.